Sign in
4

Changes in Ownership

Atara Biotherapeutics, Inc. Filed Acc 0001140361-23-025561

EVP, Chief Technical Officer sold 19,040 shares at $2.04 ($38,784)

From the SEC's structured data for this filing

Trades in this filing

Banard Charlene A. · EVP, Chief Technical Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2023-05-16 Sale : show line 1 in the form −19,040 $2.04 $38,784 276,010 D
Open-market sales · 19,040 sh · avg $2.04 · $38,784
Loading xslF345X04/form4.xml…